STRO icon

Sutro Biopharma
STRO

Overview Fund Activity

113 hedge funds and large institutions have $280M invested in Sutro Biopharma in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 49 increasing their positions, 32 reducing their positions, and 12 closing their positions.

Holders
113
Holders Change
-1
Holders Change %
-0.88%
% of All Funds
1.95%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
49
Reduced
32
Closed
12
Calls
$191K
Puts
–
Net Calls
+$191K
Net Calls Change
+$499K

Top Buyers

1
CS
1
Candriam SCA
Luxembourg
$9.98M
2
Point72 Asset Management
2
Point72 Asset Management
Connecticut
$3.95M
3
Verition Fund Management
3
Verition Fund Management
Connecticut
$6.96M
4
PHP
4
Parkman Healthcare Partners
Connecticut
$3.82M
5
RCMNY
5
Rubric Capital Management (New York)
New York
$7.77M

Top Sellers

1
BS
1
Banco Santander
Spain
$0
2
Citadel Advisors
2
Citadel Advisors
Florida
$1.68M
3
Jacobs Levy Equity Management
3
Jacobs Levy Equity Management
New Jersey
$4.13M
4
Federated Hermes
4
Federated Hermes
Pennsylvania
$17K
5
GCM
5
Graham Capital Management
Connecticut
$0
Name Market Value Shares Shares
Change 		Shares
Change %
SCM
1
Suvretta Capital Management
New York
$27.9M 5,020,000 +375,000 +8%
BlackRock
2
BlackRock
New York
$22.2M 4,008,370 +285,745 +8%
Franklin Resources
3
Franklin Resources
California
$21M 3,788,780 +14,885 +0.4%
BI
4
BVF Inc
California
$19.1M 3,447,946 – –
Holocene Advisors
5
Holocene Advisors
New York
$15.6M 2,805,197 – –
EAM
6
Eventide Asset Management
Massachusetts
$15M 2,708,975 – –
Millennium Management
7
Millennium Management
New York
$14.1M 2,537,070 +230,278 +10%
Vanguard Group
8
Vanguard Group
Pennsylvania
$11.4M 2,050,276 +12,951 +0.6%
Baillie Gifford & Co
9
Baillie Gifford & Co
United Kingdom
$10.4M 1,868,615 +3,435 +0.2%
CS
10
Candriam SCA
Luxembourg
$9.98M 1,798,838 +1,736,225 +2,773%
FLSM
11
Frazier Life Sciences Management
California
$9.86M 1,776,479 – –
SB
12
Samsara BioCapital
California
$9.3M 1,675,579 – –
RCMNY
13
Rubric Capital Management (New York)
New York
$7.77M 1,400,000 +500,000 +56%
Verition Fund Management
14
Verition Fund Management
Connecticut
$6.96M 1,254,105 +529,024 +73%
Goldman Sachs
15
Goldman Sachs
New York
$5.22M 940,571 +434,511 +86%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$4.72M 850,747 +35,958 +4%
State Street
17
State Street
Massachusetts
$4.6M 827,885 +24,300 +3%
Fidelity Investments
18
Fidelity Investments
Massachusetts
$4.14M 746,455 +82,044 +12%
Jacobs Levy Equity Management
19
Jacobs Levy Equity Management
New Jersey
$4.13M 743,228 -273,806 -27%
Point72 Asset Management
20
Point72 Asset Management
Connecticut
$3.95M 711,000 +711,000 New
PHP
21
Parkman Healthcare Partners
Connecticut
$3.82M 687,335 +502,817 +273%
Acadian Asset Management
22
Acadian Asset Management
Massachusetts
$3.5M 631,800 -29,815 -5%
Marshall Wace
23
Marshall Wace
United Kingdom
$2.91M 523,621 -50,618 -9%
Dimensional Fund Advisors
24
Dimensional Fund Advisors
Texas
$2.53M 456,583 +92,938 +26%
Northern Trust
25
Northern Trust
Illinois
$2.26M 406,772 +29,792 +8%
1
2 3 4 5